Open-Ring Butenolides from a Marine-Derived Anti-Neuroinflammatory Fungus Aspergillus terreus Y10

Mar Drugs. 2018 Nov 2;16(11):428. doi: 10.3390/md16110428.

Abstract

To investigate structurally novel and anti-neuroinflammatory natural compounds from marine-derived microorganisms, the secondary metabolites of Aspergillus terreus Y10, a fungus separated from the sediment of the coast in the South China Sea, were studied. Three new compounds (24), with novel open-ring butenolide skeletons, were isolated from the ethyl acetate extract of the culture medium. In addition, a typical new butenolide, asperteretal F (1), was found to dose-dependently inhibit tumor necrosis factor (TNF-α) generation with an IC50 of 7.6 μg/mL. The present study shows the existence of open-ring butenolides, and suggests that butenolides such as asperteretal F (1) are a promising new anti-neuroinflammatroy candidate for neurodegenerative diseases.

Keywords: Aspergillus terreus Y10; G1; G2; H; anti-neuroinflammatory activity; asperteretal F; microglial; open-ring butenolide.

MeSH terms

  • 4-Butyrolactone / analogs & derivatives*
  • 4-Butyrolactone / chemistry
  • 4-Butyrolactone / isolation & purification
  • 4-Butyrolactone / pharmacology
  • 4-Butyrolactone / therapeutic use
  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / isolation & purification
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Aquatic Organisms / metabolism*
  • Aspergillus / metabolism*
  • Biological Products / chemistry
  • Biological Products / isolation & purification
  • Biological Products / pharmacology*
  • Biological Products / therapeutic use
  • Cell Line
  • Humans
  • Inhibitory Concentration 50
  • Lipopolysaccharides / immunology
  • Mice
  • Microglia / drug effects
  • Microglia / immunology
  • Molecular Structure
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / immunology
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / isolation & purification
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Anti-Inflammatory Agents
  • Biological Products
  • Lipopolysaccharides
  • Neuroprotective Agents
  • Tumor Necrosis Factor-alpha
  • butenolide
  • 4-Butyrolactone